amyloid beta 42/40 ratio
Selected indexed studies
- A 19-Year-Old Adolescent with Probable Alzheimer's Disease. (J Alzheimers Dis, 2023) [PMID:36565128]
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease. (Alzheimers Res Ther, 2019) [PMID:31010420]
- The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults. (Neurobiol Aging, 2024) [PMID:39241563]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- A 19-Year-Old Adolescent with Probable Alzheimer's Disease. (2023) pubmed
- Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease. (2019) pubmed
- The amyloid beta 42/38 ratio as a plasma biomarker of early memory deficits in cognitively unimpaired older adults. (2024) pubmed
- The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease. (2023) pubmed
- Portable platform for measuring amyloid beta 42/40 ratio via photooxidation-induced fluorescence amplification. (2025) pubmed
- Subjective cognitive decline in conjunction with cerebrospinal fluid anti-ATP1A3 autoantibodies and a low amyloid β 1-42/1-40 ratio: Report and literature review. (2025) pubmed
- Prognostic Role of CSF β-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis. (2021) pubmed
- Prospective Associations between Plasma Amyloid-Beta 42/40 and Frailty in Community-Dwelling Older Adults. (2021) pubmed
- Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity. (2024) pubmed
- β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis. (2012) pubmed